Generate Biomedicines
Clinical trials sponsored by Generate Biomedicines, explained in plain language.
-
New Twice-Yearly shot tested as potential Game-Changer for severe asthma
Disease control Recruiting nowThis study is testing an investigational drug called GB-0895 for people with severe asthma that isn't well-managed by their current inhalers. About 786 participants, aged 12 to 80, will receive either the real drug or a placebo injection every six months for a year to see if it s…
Phase: PHASE3 • Sponsor: Generate Biomedicines • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
New injection offers hope for severe asthma sufferers
Disease control Recruiting nowThis study is testing whether adding a new drug called GB-0895 helps people with severe asthma that isn't controlled by their usual high-dose inhalers. About 786 participants, aged 12 to 80, will receive either GB-0895 or a placebo injection every six months for a year to see if …
Phase: PHASE3 • Sponsor: Generate Biomedicines • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC